6 research outputs found

    Π ΠΠ‘Π¨Π˜Π Π•ΠΠ˜Π• Π’ΠžΠ—ΠœΠžΠ–ΠΠžΠ‘Π’Π•Π™ ΠŸΠ ΠžΠ’Π˜Π’ΠžΠžΠŸΠ£Π₯ΠžΠ›Π•Π’ΠžΠ“Πž Π›Π•Π§Π•ΠΠ˜Π― ПРИ ΠŸΠ ΠžΠ’Π•Π”Π•ΠΠ˜Π˜ ΠΠΠŸΠ ΠΠ’Π›Π•ΠΠΠžΠ™ ΠΠΠ’Π˜ΠœΠ˜ΠšΠ ΠžΠ‘ΠΠžΠ™ Π’Π•Π ΠΠŸΠ˜Π˜. ΠžΠŸΠ˜Π‘ΠΠΠ˜Π• БЛУЧАЯ

    Get PDF
    Introduction. Penile cancer (pc) is a rare cancer. The standardized incidence rate of pc in russia is 0.82 cases per 100,000 males. On average, 58 % of patients (20–96 %) with pc have a local infection process: tumor decay, the presence of erosion, tumor ulceration, inflammatory changes in regional lymph nodes, etc. During hospitalization nosocomial pathogens may be possible causes of infection in ulcerative lesions.The aim of the study was to present the results of the treatment of tumor ulcer in a patient with penile cancer infected with multiresistant acinetobacter baumannii and klebsiella pneumoniae.Material and methods. We present a clinical observation of 54-year-old patient diagnosed with penile cancer pt4n3m0, with ulceration of the tumor, localized at the root of the penis and ulceration of metastatic lymph nodes in the left inguinal region and subsequent infection with highly resistant nosocomial microorganisms.Results. The patient received 6 courses of paclitaxel, ifosfamide and cisplatin with clinical effect, such as significant reduction of the tumor and therapeutic pathomorphosis of 3-rd degree. Then ileo-inguinal lymphadenectomy was performed on the left. A few months later the tumor continued to grow in the left groin area. During the 2nd line of chemotherapy (cisplatin, docetaxel and capecitabine), the patient had grade iii–iv neutropenia, febrile neutropenia. High fever and localized infection in the area of tumor ulceration with multiresistant hospital microorganisms was detected. Combined antibiotic therapy had temporary effect. After isolation of multiresistant carbapenemresistant k. Pneumoniae from the ulcer, the patient was prescribed ceftazidim/avibactam 2.5 g 3 times a day. Clinical effect, such as defervescence and significant reduction of the ulceration zone was seen subsequently.Conclusion. Etiotropic antibacterial therapy of the infected tumor ulcer resulted in a significant reduction in the manifestation of the infection process, allowing antitumor therapy to be continued, as well as surgery to be performed.ΠΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ. Π Π°ΠΊ ΠΏΠΎΠ»ΠΎΠ²ΠΎΠ³ΠΎ Ρ‡Π»Π΅Π½Π° являСтся Ρ€Π΅Π΄ΠΊΠΎΠΉ онкологичСской ΠΏΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΠ΅ΠΉ. Π‘Ρ‚Π°Π½Π΄Π°Ρ€Ρ‚ΠΈΠ·ΠΈΡ€ΠΎΠ²Π°Π½Π½Ρ‹ΠΉ ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΡŒ заболСваСмости Π² России Ρ€Π°Π²Π΅Π½ 0,82 случая Π½Π° 100 тыс. муТского насСлСния. Π’ срСднСм Ρƒ 58 % Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… (20–96 %) Ρ€Π°ΠΊΠΎΠΌ ΠΏΠΎΠ»ΠΎΠ²ΠΎΠ³ΠΎ Ρ‡Π»Π΅Π½Π° ΠΈΠΌΠ΅ΡŽΡ‚ΡΡ распад ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ, эрозии, изъязвлСния ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅Π²ΠΎΠ³ΠΎ ΡƒΠ·Π»Π°, Π²ΠΎΡΠΏΠ°Π»ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ измСнСния Ρ€Π΅Π³ΠΈΠΎΠ½Π°Ρ€Π½Ρ‹Ρ… Π»ΠΈΠΌΡ„ΠΎΡƒΠ·Π»ΠΎΠ² ΠΈ Ρ‚. Π΄. с присоСдинСниСм Π²Ρ‚ΠΎΡ€ΠΈΡ‡Π½ΠΎΠΉ ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΈ. ΠŸΡ€ΠΈ Π½Π°Ρ…ΠΎΠΆΠ΄Π΅Π½ΠΈΠΈ больного Π² стационарС Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎ ΠΈΠ½Ρ„ΠΈΡ†ΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠ΅ язвСнных ΠΏΠΎΡ€Π°ΠΆΠ΅Π½ΠΈΠΉ Π³ΠΎΡΠΏΠΈΡ‚Π°Π»ΡŒΠ½Ρ‹ΠΌΠΈ ΠΏΠ°Ρ‚ΠΎΠ³Π΅Π½Π°ΠΌΠΈ.ЦСль исслСдования – ΠΏΡ€Π΅Π΄ΡΡ‚Π°Π²ΠΈΡ‚ΡŒ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ лСчСния ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅Π²ΠΎΠΉ язвы Ρƒ больного Ρ€Π°ΠΊΠΎΠΌ ΠΏΠΎΠ»ΠΎΠ²ΠΎΠ³ΠΎ Ρ‡Π»Π΅Π½Π°, ΠΈΠ½Ρ„ΠΈΡ†ΠΈΡ€ΠΎΠ²Π°Π½Π½ΠΎΠΉ ΠΌΡƒΠ»ΡŒΡ‚ΠΈΡ€Π΅Π·ΠΈΡΡ‚Π΅Π½Ρ‚Π½Ρ‹ΠΌΠΈ ΡˆΡ‚Π°ΠΌΠΌΠ°ΠΌΠΈ Acinetobacter baumannii ΠΈ Klebsiella pneumoniae.ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π» ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. Π”Π°Π½ΠΎ описаниС случая лСчСния ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Π° 54 Π»Π΅Ρ‚ с Π΄ΠΈΠ°Π³Π½ΠΎΠ·ΠΎΠΌ: Ρ€Π°ΠΊ ΠΏΠΎΠ»ΠΎΠ²ΠΎΠ³ΠΎ Ρ‡Π»Π΅Π½Π° pt4N3m0 с распадом ΠΈ изъязвлСниСм ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ Π² области корня ΠΏΠΎΠ»ΠΎΠ²ΠΎΠ³ΠΎ Ρ‡Π»Π΅Π½Π° ΠΈ мСтастатичСских Π»ΠΈΠΌΡ„ΠΎΡƒΠ·Π»ΠΎΠ² Π² Π»Π΅Π²ΠΎΠΉ ΠΏΠ°Ρ…ΠΎΠ²ΠΎΠΉ области ΠΈ ΠΈΡ… ΠΈΠ½Ρ„ΠΈΡ†ΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΌΡƒΠ»ΡŒΡ‚ΠΈΡ€Π΅Π·ΠΈΡΡ‚Π΅Π½Ρ‚Π½Ρ‹ΠΌΠΈ Π³ΠΎΡΠΏΠΈΡ‚Π°Π»ΡŒΠ½Ρ‹ΠΌΠΈ ΠΌΠΈΠΊΡ€ΠΎΠΎΡ€Π³Π°Π½ΠΈΠ·ΠΌΠ°ΠΌΠΈ.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. ΠŸΠ°Ρ†ΠΈΠ΅Π½Ρ‚ ΠΏΠΎΠ»ΡƒΡ‡ΠΈΠ» 6 курсов ΠΏΠΎΠ»ΠΈΡ…ΠΈΠΌΠΈΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΠΈ паклитаксСлом, ифосфамидом ΠΈ цисплатином c клиничСским эффСктом Π² Π²ΠΈΠ΄Π΅ Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ ΡƒΠΌΠ΅Π½ΡŒΡˆΠ΅Π½ΠΈΡ Ρ€Π°Π·ΠΌΠ΅Ρ€ΠΎΠ² ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ ΠΈ iii стСпСни Π»Π΅Ρ‡Π΅Π±Π½ΠΎΠ³ΠΎ ΠΏΠ°Ρ‚ΠΎΠΌΠΎΡ€Ρ„ΠΎΠ·Π°. Π‘Ρ‹Π»Π° Π²Ρ‹ΠΏΠΎΠ»Π½Π΅Π½Π° ΠΏΠ°Ρ…ΠΎΠ²ΠΎ-подвздошная лимфадСнэктомия слСва, послС ΠΊΠΎΡ‚ΠΎΡ€ΠΎΠΉ Ρ‡Π΅Ρ€Π΅Π· нСсколько мСсяцСв Π±Ρ‹Π» ΠΎΡ‚ΠΌΠ΅Ρ‡Π΅Π½ ΠΏΡ€ΠΎΠ΄ΠΎΠ»ΠΆΠ΅Π½Π½Ρ‹ΠΉ рост ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ. Π’ процСссС 2-ΠΉ Π»ΠΈΠ½ΠΈΠΈ ΠΏΠΎΠ»ΠΈΡ…ΠΈΠΌΠΈΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΠΈ цисплатином, доцСтаксСлом ΠΈ ΠΊΠ°ΠΏΠ΅Ρ†ΠΈΡ‚Π°Π±ΠΈΠ½ΠΎΠΌ Ρƒ больного ΠΎΡ‚ΠΌΠ΅Ρ‡Π°Π»Π°ΡΡŒ нСйтропСния iii–iV стСпСни, Ρ„Π΅Π±Ρ€ΠΈΠ»ΡŒΠ½Π°Ρ нСйтропСния. На Ρ„ΠΎΠ½Π΅ высокой Π»ΠΈΡ…ΠΎΡ€Π°Π΄ΠΊΠΈ Π±Ρ‹Π»ΠΎ выявлСно ΠΈΠ½Ρ„ΠΈΡ†ΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠ΅ язвСнных Π΄Π΅Ρ„Π΅ΠΊΡ‚ΠΎΠ² ΠΌΡƒΠ»ΡŒΡ‚ΠΈΡ€Π΅Π·ΠΈΡΡ‚Π΅Π½Ρ‚Π½Ρ‹ΠΌΠΈ Π³ΠΎΡΠΏΠΈΡ‚Π°Π»ΡŒΠ½Ρ‹ΠΌΠΈ ΠΌΠΈΠΊΡ€ΠΎΠΎΡ€Π³Π°Π½ΠΈΠ·ΠΌΠ°ΠΌΠΈ. ΠŸΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»Π°ΡΡŒ комбинированная антибиотикотСрапия с Π²Ρ€Π΅ΠΌΠ΅Π½Π½Ρ‹ΠΌ эффСктом. ПослС выдСлСния ΠΈΠ· Ρ€Π°Π½Ρ‹ ΠΌΡƒΠ»ΡŒΡ‚ΠΈΡ€Π΅Π·ΠΈΡΡ‚Π΅Π½Ρ‚Π½ΠΎΠΉ K. pneumoniae, рСзистСнтной Π² Ρ‚ΠΎΠΌ числС ΠΊ ΠΊΠ°Ρ€Π±Π°ΠΏΠ΅Π½Π΅ΠΌΠ°ΠΌ, ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Ρƒ Π±Ρ‹Π» Π½Π°Π·Π½Π°Ρ‡Π΅Π½ Ρ†Π΅Ρ„Ρ‚Π°Π·ΠΈΠ΄ΠΈΠΌ/Π°Π²ΠΈΠ±Π°ΠΊΡ‚Π°ΠΌ 2,5 Π³ 3 Ρ€Π°Π·Π° Π² сут. На Ρ„ΠΎΠ½Π΅ лСчСния отмСчался клиничСский эффСкт Π² Π²ΠΈΠ΄Π΅ Π½ΠΎΡ€ΠΌΠ°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ Ρ‚Π΅ΠΌΠΏΠ΅Ρ€Π°Ρ‚ΡƒΡ€Ρ‹ ΠΈ Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ ΡƒΠΌΠ΅Π½ΡŒΡˆΠ΅Π½ΠΈΡ Π·ΠΎΠ½ изъязвлСния ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅ΠΉ.Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. ΠŸΡ€ΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ Π½Π°ΠΏΡ€Π°Π²Π»Π΅Π½Π½ΠΎΠΉ Π°Π½Ρ‚ΠΈΠ±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ ΠΈΠ½Ρ„ΠΈΡ†ΠΈΡ€ΠΎΠ²Π°Π½Π½ΠΎΠΉ ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅Π²ΠΎΠΉ язвы Π½Π° основС Π΄Π°Π½Π½Ρ‹Ρ… микробиологичСских исслСдований ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΠ»ΠΎ Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎ ΡƒΠΌΠ΅Π½ΡŒΡˆΠΈΡ‚ΡŒ проявлСния ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ процСсса ΠΈ ΠΏΡ€ΠΎΠ΄ΠΎΠ»ΠΆΠΈΡ‚ΡŒ ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ лСкарствСнной ΠΏΡ€ΠΎΡ‚ΠΈΠ²ΠΎΠΎΠΏΡƒΡ…ΠΎΠ»Π΅Π²ΠΎΠΉ Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ, Π° Ρ‚Π°ΠΊΠΆΠ΅ Π² дальнСйшСм Π²Ρ‹ΠΏΠΎΠ»Π½ΠΈΡ‚ΡŒ ΠΎΠΏΠ΅Ρ€Π°Ρ‚ΠΈΠ²Π½ΠΎΠ΅ Π²ΠΌΠ΅ΡˆΠ°Ρ‚Π΅Π»ΡŒΡΡ‚Π²ΠΎ

    Π˜ΠΠ€Π•ΠšΠ¦Π˜ΠžΠΠΠ«Π• ΠžΠ‘Π›ΠžΠ–ΠΠ•ΠΠ˜Π― ΠŸΠžΠ‘Π›Π• Π Π•ΠšΠžΠΠ‘Π’Π Π£ΠšΠ’Π˜Π’ΠΠ«Π₯ ΠžΠŸΠ•Π ΠΠ’Π˜Π’ΠΠ«Π₯ Π’ΠœΠ•Π¨ΠΠ’Π•Π›Π¬Π‘Π’Π’ Π£ Π‘ΠžΠ›Π¬ΠΠ«Π₯ РАКОМ ΠœΠžΠ›ΠžΠ§ΠΠžΠ™ Π–Π•Π›Π•Π—Π«. ΠžΠŸΠ˜Π‘ΠΠΠ˜Π• ΠšΠ›Π˜ΠΠ˜Π§Π•Π‘ΠšΠžΠ“Πž БЛУЧАЯ

    Get PDF
    Introduction. Currently, there is no global consensus regarding the management of breast cancer patients with implant-associated infections. Some studies clearly recommend their removal and surgical debridement with consecutive antimicrobial treatment, while others prefer long-term antibacterial therapy (at least 1 month) with the effectiveness of such conservative approach of 36–73 %.Case description. A 43-year-old patient suffering from brca1-positive right breast cancer t2n0m0 (invasive carcinoma of non-specific type g3, er – 8, pgr – 0, her-2/neu – 0, ki67 (%) – less than 20 %), underwent radical skin-preserving mastectomy on the right with simultaneous implant reconstruction and preventive subcutaneous mastectomy on the left with simultaneous implant reconstruction. Peri-implant infection in the left breast was observed on the 21st day after surgery.Results. The patient received empirical therapy with cefepim. Microbiological examination of the punctate revealed the causative agent of infection – methicillin-resistant staphylococcus aureus (mrsa) (1Γ—105cfu/ml). Daptomycin 6 mg/kg/day was added to therapy. After 8 weeks, the patient received oral moxifloxacin 400 once daily, for another 3 weeks. A complete response was achieved. The patient has no signs of infection for 3 years.Conclusion. Long-term etiotropic antibacterial therapy with daptomycin followed by oral moxifloxacin resulted in a stable clinical effect.ΠΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ. Π’ настоящСС врСмя Π² ΠΌΠΈΡ€Π΅ Π½Π΅Ρ‚ Π΅Π΄ΠΈΠ½ΠΎΠ³ΠΎ мнСния Π² ΠΎΡ‚Π½ΠΎΡˆΠ΅Π½ΠΈΠΈ Ρ‚Π°ΠΊΡ‚ΠΈΠΊΠΈ вСдСния ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠΊ с Ρ€Π°ΠΊΠΎΠΌ ΠΌΠΎΠ»ΠΎΡ‡Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹ с ΠΈΠΌΠΏΠ»Π°Π½Ρ‚-ассоциированными инфСкциями. Π’ ΠΎΠ΄Π½ΠΈΡ… исслСдованиях ΠΎΠ΄Π½ΠΎΠ·Π½Π°Ρ‡Π½ΠΎ Ρ€Π΅ΠΊΠΎΠΌΠ΅Π½Π΄ΠΎΠ²Π°Π½Ρ‹ ΠΈΡ… ΡƒΠ΄Π°Π»Π΅Π½ΠΈΠ΅ ΠΈ хирургичСская санация c ΠΏΠΎΡΠ»Π΅Π΄ΡƒΡŽΡ‰Π΅ΠΉ Π°Π½Ρ‚ΠΈΠ±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ Ρ‚Π΅Ρ€Π°ΠΏΠΈΠ΅ΠΉ, Π² Π΄Ρ€ΡƒΠ³ΠΈΡ… – отдаСтся ΠΏΡ€Π΅Π΄ΠΏΠΎΡ‡Ρ‚Π΅Π½ΠΈΠ΅ Π΄Π»ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΉ Π°Π½Ρ‚ΠΈΠΌΠΈΠΊΡ€ΠΎΠ±Π½ΠΎΠΉ Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ (Π½Π΅ ΠΌΠ΅Π½Π΅Π΅ 1 мСс), ΠΏΡ€ΠΈ этом ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ консСрвативного ΠΏΠΎΠ΄Ρ…ΠΎΠ΄Π° достигаСт 36–73 %.ΠšΠ»ΠΈΠ½ΠΈΡ‡Π΅ΡΠΊΠΈΠΉ случай. ΠŸΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΊΠ΅ 43 Π»Π΅Ρ‚, ΡΡ‚Ρ€Π°Π΄Π°ΡŽΡ‰Π΅ΠΉ BRCa1-ΠΏΠΎΠ»ΠΎΠΆΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹ΠΌ Ρ€Π°ΠΊΠΎΠΌ ΠΏΡ€Π°Π²ΠΎΠΉ ΠΌΠΎΠ»ΠΎΡ‡Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹ t2n0M0 (инвазивная ΠΊΠ°Ρ€Ρ†ΠΈΠ½ΠΎΠΌΠ° нСспСцифичСского Ρ‚ΠΈΠΏΠ° G3, eR – 8, PgR – 0, Her-2/neu – 0, Ki67 (%) – ΠΌΠ΅Π½Π΅Π΅ 20 %), Π±Ρ‹Π»ΠΈ Π²Ρ‹ΠΏΠΎΠ»Π½Π΅Π½Ρ‹ Ρ€Π°Π΄ΠΈΠΊΠ°Π»ΡŒΠ½Π°Ρ коТСсохранная мастэктомия справа с ΠΎΠ΄Π½ΠΎΠΌΠΎΠΌΠ΅Π½Ρ‚Π½ΠΎΠΉ рСконструкциСй ΠΈΠΌΠΏΠ»Π°Π½Ρ‚ΠΎΠΌ ΠΈ профилактичСская подкоТная мастэктомия слСва с ΠΎΠ΄Π½ΠΎΠΌΠΎΠΌΠ΅Π½Ρ‚Π½ΠΎΠΉ рСконструкциСй ΠΈΠΌΠΏΠ»Π°Π½Ρ‚ΠΎΠΌ. Π½Π° 21-Π΅ сут послС ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΈ Ρ€Π°Π·Π²ΠΈΠ»Π°ΡΡŒ инфСкция Π² области ΠΈΠΌΠΏΠ»Π°Π½Ρ‚Π° Π»Π΅Π²ΠΎΠΉ ΠΌΠΎΠ»ΠΎΡ‡Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. ΠŸΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΊΠ΅ эмпиричСски Π±Ρ‹Π»Π° Π½Π°Π·Π½Π°Ρ‡Π΅Π½Π° тСрапия Ρ†Π΅Ρ„Π΅ΠΏΠΈΠΌΠΎΠΌ. ΠŸΡ€ΠΈ микробиологичСском исслСдовании ΠΏΡƒΠ½ΠΊΡ‚Π°Ρ‚Π° Π±Ρ‹Π» выявлСн Π²ΠΎΠ·Π±ΡƒΠ΄ΠΈΡ‚Π΅Π»ΡŒ ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΈ – ΠΌΠ΅Ρ‚ΠΈΡ†ΠΈΠ»Π»ΠΈΠ½-рСзистСнтный золотистый стафилококк (MRSA) Π² количСствС 1Γ—105ΠΊΠžΠ•/ΠΌΠ». ΠΊ Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ Π±Ρ‹Π» Π΄ΠΎΠ±Π°Π²Π»Π΅Π½ Π΄Π°ΠΏΡ‚ΠΎΠΌΠΈΡ†ΠΈΠ½ 6 ΠΌΠ³/ΠΊΠ³/сут. Π§Π΅Ρ€Π΅Π· 8 Π½Π΅Π΄ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΊΠ° Π±Ρ‹Π»Π° ΠΏΠ΅Ρ€Π΅Π²Π΅Π΄Π΅Π½Π° Π½Π° ΠΏΠ΅Ρ€ΠΎΡ€Π°Π»ΡŒΠ½Ρ‹ΠΉ моксифлоксацин 400 ΠΌΠ³ 1 Ρ€Π°Π· Π² сут, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹ΠΉ ΠΏΠΎΠ»ΡƒΡ‡Π°Π»Π° Π΅Ρ‰Π΅ 3 Π½Π΅Π΄. Π½Π° Ρ„ΠΎΠ½Π΅ лСчСния Π±Ρ‹Π» ΠΏΠΎΠ»ΡƒΡ‡Π΅Π½ ΠΏΠΎΠ»Π½Ρ‹ΠΉ эффСкт. Π‘ΠΎΠ»ΡŒΠ½Π°Ρ Π±Π΅Π· ΠΏΡ€ΠΈΠ·Π½Π°ΠΊΠΎΠ² ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΈ Π² Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ 3 Π»Π΅Ρ‚.Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. Π”Π»ΠΈΡ‚Π΅Π»ΡŒΠ½Π°Ρ этиотропная Π°Π½Ρ‚ΠΈΠ±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠ°Π»ΡŒΠ½Π°Ρ тСрапия с использованиСм Π΄Π°ΠΏΡ‚ΠΎΠΌΠΈΡ†ΠΈΠ½Π° с ΠΏΠ΅Ρ€Π΅Ρ…ΠΎΠ΄ΠΎΠΌ Π½Π° ΠΏΠ΅Ρ€ΠΎΡ€Π°Π»ΡŒΠ½Ρ‹ΠΉ моксифлоксацин ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΠ»Π° ΠΏΠΎΠ»ΡƒΡ‡ΠΈΡ‚ΡŒ стойкий клиничСский эффСкт ΠΈ своСврСмСнно провСсти Π°Π΄ΡŠΡŽΠ²Π°Π½Ρ‚Π½ΠΎΠ΅ ΠΏΡ€ΠΎΡ‚ΠΈΠ²ΠΎΠΎΠΏΡƒΡ…ΠΎΠ»Π΅Π²ΠΎΠ΅ Π»Π΅Ρ‡Π΅Π½ΠΈΠ΅

    INFECTIOUS COMPLICATIONS CAUSED BY NON-SPOREFORMING ANAEROBIC BACTERIA IN CANCER PATIENTS. RELEVANCE OF THE PROBLEM

    Get PDF
    The purpose of the study: to identify the significance of anaerobic bacteria and analyze their role in the development of infectious complications in cancer patients. Material and Methods. The review includes data from clinical and in vitro studies published in Russian and international press for the period from 1989 to 2018. Results. Data analysis has shown that many aspects related to anaerobic non-sporeforming bacteria are insufficiently studied, although they can cause severe hospital infections. This is especially true for patients with immune system defects, including cancer patients. In this category of patients, anaerobic bacteria can cause infections of the maxillofacial region, intra-abdominal infections, lower respiratory tract infections, urinary infections, and blood flow infections. In cancer patients, infectious complications are more severe, and may adversely affect treatment outcomes. A long process of anaerobic cultivation dictates the need for empirical treatment of infection for an average of 6 to 7 days. Since the middle of the last century, metronidazole was the Β«gold standardΒ» of therapy. However, today the situation has changed dramatically. More than 80 % of anaerobic strains are resistant to metronidazole. The problem of resistance of anaerobic bacteria to other antibacterial drugs has not been sufficiently studied. Conclusion. It is necessary to develop therapeutic approaches based on current data on the resistance mechanisms of non-sporeforming anaerobic bacteria

    Interacting with Broadband Society

    No full text
    This book discusses the personal and social lives of e-actors inteeracting within the socio-technical structures of the evolving broadband society by exploring the different ways in which individuals, social groups, institutions, operators, manufacturers, policy makers, designers and other parties contribute to human communication and social interaction in contemporary media societies. The volume covers four theoretical and empirical areas of research: the conceptual perspectives of e-actors, the emergence of new forms of agency, subjectivity, and mediated interpersonal communication, the everyday life experiences of e-actors, and finally the shaping policies and regulations in the broadband society
    corecore